Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07536061 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease

Name: A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease — clinical trial record (NCT07536061)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorSarepta Therapeutics, Inc.

Started2026-05-12

View on ClinicalTrials.gov ↗

Amendment history

2026-09-03

Study Status, Contacts/Locations v2

Study sites2→4

2026-06-03

Study Status, Contacts/Locations v1

Recruitment opened

Start dateestimated 2026-05-05→confirmed 2026-05-12

Study sitesdetails revised at 2 of 2 sites

2026-04-10

Original filing

Sarepta Therapeutics, Inc.

14 trials monitored

See 3 trials at risk

Huntington's Disease

78 trials monitored

See 3 trials at risk

This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).

Trial Details

NCT Number	NCT07536061
Lead Sponsor	Sarepta Therapeutics, Inc.
Conditions	Huntington's Disease
Enrollment	32 participants
Start Date	2026-05-12
Primary Completion	2027-11-30 (estimated)
Study Completion	2027-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-04